Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating amantadine for neurologic symptoms in Ataxia-telangiectasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Ataxia, Chorea | Phase 4 | Status: COMPLETED